Application of mercaptonicotinic acid compounds
The invention discloses application of substituted mercaptonicotinic acid compounds. The general structural formula of the compounds is shown in a formula I which is described in the specification, and the mercaptonicotinic acid compounds comprise pharmaceutically acceptable salts, esters and solvat...
Saved in:
Main Authors | , , , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
26.11.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention discloses application of substituted mercaptonicotinic acid compounds. The general structural formula of the compounds is shown in a formula I which is described in the specification, and the mercaptonicotinic acid compounds comprise pharmaceutically acceptable salts, esters and solvates. Pharmacodynamic test results show that the mercaptonicotinic acid compounds as shown in the formula I can inhibit activity of botulinum neurotoxin endopeptidase and tetanus toxin endopeptidase in vitro and exert an obvious protective effect on mice poisoned by botulinum neurotoxin. Thus, the compounds provided by the invention can be used for preparation of drugs used for prevention and/or treatment of botulinum neurotoxin exposure and/or poisoning and for preparation of drugs used for prevention and/or treatment of tetanus. |
---|---|
Bibliography: | Application Number: CN20131187415 |